Cannabis and Cannabinoid Research Publishes Data Demonstrating the Degradation of Cannabidiol to Psychoactive Cannabinoids when Exposed to Simulated Gastric Fluid
April 12, 2016 07:00 ET
|
Zynerba Pharmaceuticals, Inc.
DEVON, Pa., April 12, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic...
Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference
March 30, 2016 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 30, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Zynerba Pharmaceuticals Initiates Phase 1 Clinical Trial for ZYN002 CBD Gel
October 20, 2015 07:05 ET
|
Zynerba Pharmaceuticals, Inc.
DEVON, Pa., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic...
Transdermal Drug Patches to 2018 Products, Indications, Markets and Forecasts
November 05, 2013 10:39 ET
|
Research and Markets
Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/z2tvzf/transdermal_drug)
has announced the addition of the
"Transdermal Drug Patches to 2018...
InvisiDerm Healthcare Completes Successful Clinical Trial of Transdermal Delivery, Discusses Medical Applications
November 12, 2012 09:17 ET
|
InvisiDerm Healthcare
PASADENA, Calif., Nov. 12, 2012 (GLOBE NEWSWIRE) -- InvisiDerm Healthcare ("InvisiDerm"), developer and manufacturer of noninvasive gas and drug delivery methods, announced the completion of the...